Sagimet Biosciences Inc (SGMT) insider trading
Every open-market stock purchase and sale by Sagimet Biosciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $395K over the last 12 months (5 sales). No open-market buys.
- Last insider buy: David Happel (CEO), $63.7K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $395K (5 sales). Last close $6.53 on Jun 7, 2026.
Recent SGMT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 12, 2026 | Paul W. Hoelscher (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Jennifer Jarrett (Director) | Bought (not open market) | — |
| Jun 12, 2026 | George Kemble (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Anne M. Phillips (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Beth C Seidenberg (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Elizabeth A Grammer (Director) | Bought (not open market) | — |
| May 28, 2026 | David Happel (CEO) | Bought (not open market) | — |
| May 28, 2026 | Thierry Chauche (CFO) | Bought (not open market) | — |
| May 28, 2026 | Andreas Grauer (C-suite exec) | Bought (not open market) | — |
| May 28, 2026 | Elizabeth Rozek (Officer) | Bought (not open market) | — |
| Apr 20, 2026 | Andreas Grauer (C-suite exec) | Bought (not open market) | — |
| Feb 19, 2026 | Elizabeth Rozek (Officer) | Bought (not open market) | — |
| Feb 19, 2026 | Eduardo Bruno Martins (C-suite exec) | Bought (not open market) | — |
| Feb 19, 2026 | David Happel (CEO) | Bought (not open market) | — |
| Feb 19, 2026 | David Happel (CEO) | Bought (not open market) | — |
| Feb 19, 2026 | Thierry Chauche (CFO) | Bought (not open market) | — |
| Feb 19, 2026 | Thierry Chauche (CFO) | Bought (not open market) | — |
| Feb 19, 2026 | Elizabeth Rozek (Officer) | Bought (not open market) | — |
| Feb 19, 2026 | Eduardo Bruno Martins (C-suite exec) | Bought (not open market) | — |
| Feb 10, 2026 | David Happel (CEO) | Sold | $64.9K |
| Feb 10, 2026 | Eduardo Bruno Martins (C-suite exec) | Sold | $19.5K |
| Feb 10, 2026 | Elizabeth Rozek (Officer) | Sold | $14.1K |
| Feb 10, 2026 | Thierry Chauche (CFO) | Sold | $7K |
| Nov 20, 2025 | George Kemble (Chair) | Sold | $290K |
| Nov 4, 2025 | Elizabeth Rozek (Officer) | Bought (not open market) | — |
Who's trading SGMT
- Anne M. Phillips, Director: other filings, last Jun 12, 2026
- Elizabeth A Grammer, Director: other filings, last Jun 12, 2026
- Paul W. Hoelscher, Director: other filings, last Jun 12, 2026
- Jennifer Jarrett, Director: other filings, last Jun 12, 2026
- Beth C Seidenberg, Director: other filings, last Jun 12, 2026
- George Kemble, Chair: sold $290K (1 sale), last Jun 12, 2026
- Thierry Chauche, CFO: sold $7K (1 sale), last May 28, 2026
- Elizabeth Rozek, Officer: sold $14.1K (1 sale), last May 28, 2026
- Andreas Grauer, C-suite exec: other filings, last May 28, 2026
- David Happel, CEO: sold $64.9K (1 sale), last May 28, 2026
- Eduardo Bruno Martins, C-suite exec: sold $19.5K (1 sale), last Feb 19, 2026
Get free alerts when an insider at Sagimet Biosciences Inc files a new trade →